| 产品描述: | 铁死亡抑制剂;Ferroptosis Inhibitors;;InformationSRS16-86 SRS16-86, a novel third-generation ferrostatin, is an inhibitor of ferroptosis .In vitroSRS16-86 exhibits ferroptosis-inhibiting ability in vitro by FACS analysis of erastin-treated HT-1080 cells and in NIH 3T3 cells.In vivoSRS16-86 (a novel third-generation ferrostatin) is more stable, to metabolism and plasma, and more potent, compared with the first-in-class compound ferrostatin-1 (Fer-1) to suppress ferroptosis in vivo. Even in conditions with extraordinarily severe IRI, SRS16-86 exerts strong protection to an extent which has not previously allowed survival in any murine setting.Cell Research(from reference)Concentrations:1 μM Incubation Time:24 h, 40 h |
| 体内研究: |
SRS16-86 (1 μM;24 小时;在存在或不存在 erastin 的情况下) 抑制 HT-1080 细胞和 NIH 3T3 细胞的铁死亡。 |
| 参考文献: |
1. Sam Hofmans, et al. Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties. J Med Chem. 2016 Mar 10;59(5):2041-53. 2. Andreas Linkermann, et al. Synchronized renal tubular cell death involves ferroptosis.Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16836-41. 3. Yan Zhang, et al. Ferroptosis inhibitor SRS 16-86 attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury. Brain Res. 2019 Mar 1;1706:48-57. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.312 ml |
11.559 ml |
23.118 ml |
| 5 mM |
0.462 ml |
2.312 ml |
4.624 ml |
| 10 mM |
0.231 ml |
1.156 ml |
2.312 ml |
| 50 mM |
0.046 ml |
0.231 ml |
0.462 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |